rdf:type |
|
lifeskim:mentions |
umls-concept:C0002499,
umls-concept:C0006968,
umls-concept:C0008976,
umls-concept:C0020028,
umls-concept:C0034656,
umls-concept:C0087111,
umls-concept:C0250480,
umls-concept:C0746883,
umls-concept:C1274040,
umls-concept:C1516213,
umls-concept:C1880496
|
pubmed:issue |
8
|
pubmed:dateCreated |
2010-7-27
|
pubmed:abstractText |
Empirical beta-lactam monotherapy has become the standard therapy in febrile neutropenia. The aim of this study was to compare the efficacy and safety of piperacillin-tazobactam versus carbapenem therapy with or without amikacin in adult patients with febrile neutropenia.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
1465-3621
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
40
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
761-7
|
pubmed:meshHeading |
pubmed-meshheading:20427546-Adolescent,
pubmed-meshheading:20427546-Adult,
pubmed-meshheading:20427546-Aged,
pubmed-meshheading:20427546-Aged, 80 and over,
pubmed-meshheading:20427546-Amikacin,
pubmed-meshheading:20427546-Anti-Bacterial Agents,
pubmed-meshheading:20427546-Antineoplastic Agents,
pubmed-meshheading:20427546-Bacterial Infections,
pubmed-meshheading:20427546-Carbapenems,
pubmed-meshheading:20427546-Drug Eruptions,
pubmed-meshheading:20427546-Drug Therapy, Combination,
pubmed-meshheading:20427546-Female,
pubmed-meshheading:20427546-Fever,
pubmed-meshheading:20427546-Humans,
pubmed-meshheading:20427546-Male,
pubmed-meshheading:20427546-Middle Aged,
pubmed-meshheading:20427546-Multivariate Analysis,
pubmed-meshheading:20427546-Neoplasms,
pubmed-meshheading:20427546-Neutropenia,
pubmed-meshheading:20427546-Penicillanic Acid,
pubmed-meshheading:20427546-Piperacillin,
pubmed-meshheading:20427546-Prospective Studies,
pubmed-meshheading:20427546-Survival Rate,
pubmed-meshheading:20427546-Young Adult
|
pubmed:year |
2010
|
pubmed:articleTitle |
Piperacillin-tazobactam versus carbapenem therapy with and without amikacin as empirical treatment of febrile neutropenia in cancer patients: results of an open randomized trial at a university hospital.
|
pubmed:affiliation |
Department of Infectious Diseases and Clinical Microbiology, Zonguldak Karaelmas University School of Medicine, 67600 Zonguldak, Turkey. nefiseoztoprak@yahoo.com
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial
|